ResMed RMD Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $7.85M+0.5% | $7.81M-0.2% | $7.82M-16.5% | $9.37M+25.8% | $7.44M-2.5% | ||
| $1.72M+13.4% | $1.52M+1.7% | $1.49M+17.3% | $1.27M+279% | $335K-68.9% | ||
| -$10.13M-3,410% | $306K+105% | -$6.19M-144% | -$2.53M+55.1% | -$5.65M-292% | ||
| $398.73M+1.6% | $392.59M+12.6% | $348.54M-8.2% | $379.71M+4.0% | $365.04M+5.9% | ||
| -$10.13M— | —— | -$6.19M-144% | -$2.53M+55.1% | -$5.65M-292% | ||
| $11.25M-4.4% | $11.76M-1.6% | $11.96M+0.2% | $11.93M+9.5% | $10.9M-1.4% | ||
| $12.29M+54.6% | $7.95M-9.6% | $8.79M+52.7% | $5.76M+626% | $793K+202% | ||
| —— | —— | —— | $0— | $0— | ||
| $71.67M-51.4% | $147.55M+138% | $61.87M+282% | $16.18M— | —— | ||
| $103.88M+876% | $10.65M+39.4% | $7.64M-84.4% | $49.09M-22.2% | $63.09M+1,395% | ||
| $16.86M-76.8% | $72.68M+343% | -$29.97M-675% | $5.22M-87.0% | $40.03M-41.0% | ||
| -$12.48M+52.2% | -$26.13M-278% | $14.66M-54.4% | $32.13M— | —— | ||
| $48.34M-54.6% | $106.39M+4,702% | -$2.31M+95.1% | -$47.02M+40.8% | -$79.36M-282% | ||
| $6.53M-1.2% | $6.61M-3.5% | $6.85M-0.9% | $6.91M-51.4% | $14.22M— | ||
| -$255.24M+1.2% | -$258.35M-12.2% | -$230.27M-40.5% | -$163.89M-13.8% | -$144.07M+2.3% | ||
| -$58.03M-13.9% | -$50.94M+3.1% | -$52.58M+60.7% | -$133.71M-321% | -$31.79M+13.4% | ||
| $554.13M+63.1% | $339.75M-25.7% | $457.32M-15.1% | $538.77M-6.9% | $578.66M+87.5% | ||
| —— | —— | —— | $6.28M— | $0— | ||
| $175.01M0.0% | $175.01M+16.7% | $150.01M+50.0% | $100.01M+33.3% | $75.03M+0.1% | ||
| $87.24M-0.4% | $87.58M-0.2% | $87.75M+13.1% | $77.59M-0.1% | $77.7M0.0% | ||
| $24.88M— | —— | $522K-99.6% | $138.58M— | $0-100% | ||
| $24.88M— | —— | $522K-99.6% | $138.58M— | $0-100% | ||
| —— | —— | $2.81M-73.9% | $10.78M— | $0+100% | ||
| $20.13M+376% | $4.23M+94.7% | $2.17M+7.9% | $2.01M-1.9% | $2.05M+105% | ||
| $33.65M+17.9% | $28.54M-33.6% | $42.97M+40.5% | $30.59M+47.1% | $20.8M+0.7% | ||
| $7.43M-74.9% | $29.56M+260% | $8.21M-72.8% | $30.16M+234% | $9.02M-66.4% | ||
| —— | $5M— | $0-100% | $5M— | $0-100% | ||
| $26.79M-7.4% | $28.94M+36.8% | $21.16M-14.5% | $24.75M+2.6% | $24.12M+6.6% | ||
| $558.79M+3.2% | $541.55M+9.6% | $494.24M-4.6% | $518.17M+10.3% | $469.94M+1.4% | ||
| $499.81M+1.7% | $491.66M+10.1% | $446.54M-1.8% | $454.54M+6.6% | $426.27M+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ResMed's revenue?
- ResMed (RMD) generated $5.5B in revenue over the trailing twelve months, up 10.3% year over year.
- Is ResMed profitable?
- ResMed reported $1.5B in net income over the trailing twelve months, a 27.4% net margin.
- What are ResMed's profit margins?
- Gross margin is 61.6% and operating margin is 34.2%, with a 27.4% net margin.
- What is ResMed's earnings per share?
- ResMed's diluted EPS over the trailing twelve months is $10.37.
- Where does ResMed's income statement data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
